du Bois A - Search Results

1

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase.

Grabowski JP, Harter P, Heitz F, Pujade-Lauraine E, Reuss A, Kristensen G, Ray-Coquard I, Heitz J, Traut A, Pfisterer J, du Bois A. Grabowski JP, et al. Among authors: du bois a. Gynecol Oncol. 2016 Mar;140(3):457-62. doi: 10.1016/j.ygyno.2016.01.022. Epub 2016 Jan 22. Gynecol Oncol. 2016. PMID: 26807488

2

Therapeutic strategies in cervical pregnancy.

Dall P, Pfisterer J, du Bois A, Wilhelm C, Pfleiderer A. Dall P, et al. Among authors: du bois a. Eur J Obstet Gynecol Reprod Biol. 1994 Sep;56(3):195-200. doi: 10.1016/0028-2243(94)90170-8. Eur J Obstet Gynecol Reprod Biol. 1994. PMID: 7821493 Review.

3

Cellular DNA content and survival in advanced ovarian carcinoma.

Pfisterer J, Kommoss F, Sauerbrei W, Renz H, du Bois A, Kiechle-Schwarz M, Pfleiderer A. Pfisterer J, et al. Among authors: du bois a. Cancer. 1994 Nov 1;74(9):2509-15. doi: 10.1002/1097-0142(19941101)74:9<2509::aid-cncr2820740919>3.0.co;2-f. Cancer. 1994. PMID: 7923008

4

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer.

du Bois A, Meerpohl HG, Madjar H, Spinner D, Dall P, Pfisterer J, Bauknecht T. du Bois A, et al. J Cancer Res Clin Oncol. 1994;120(3):173-8. doi: 10.1007/BF01202198. J Cancer Res Clin Oncol. 1994. PMID: 8263015 Clinical Trial.

5

Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.

du Bois A, Kommoss FG, Pfisterer J, Lück HJ, Meerpohl HG. du Bois A, et al. Gynecol Oncol. 1996 Jan;60(1):94-6. doi: 10.1006/gyno.1996.0017. Gynecol Oncol. 1996. PMID: 8557235

6

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer.

du Bois A, Lück HJ, Bauknecht T, Möbus V, Bochtler H, Diergarten K, Meerpohl HG. du Bois A, et al. Ann Oncol. 1997 Apr;8(4):355-61. doi: 10.1023/a:1008267419453. Ann Oncol. 1997. PMID: 9209665 Free article. Clinical Trial.

7

Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie.

du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Bauknecht T, Warm M, Schroeder W, Olbricht S, Nitz U, Jackisch C. du Bois A, et al. Semin Oncol. 1997 Aug;24(4 Suppl 11):S11-28-S11-33. Semin Oncol. 1997. PMID: 9314296 Clinical Trial.

8

First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.

du Bois A, Lück HJ, Bauknecht T, Meier W, Richter B, Kuhn W, Quaas J, Pfisterer J. du Bois A, et al. J Clin Oncol. 1999 Jan;17(1):46-51. doi: 10.1200/JCO.1999.17.1.46. J Clin Oncol. 1999. PMID: 10458217 Clinical Trial.

9

A new standard of care for treatment of ovarian cancer.

Piccart MJ, Du Bois A, Gore ME, Neijt JP, Pecorelli S, Pujade-Lauraine E. Piccart MJ, et al. Among authors: du bois a. Eur J Cancer. 2000 Jan;36(1):10-2. doi: 10.1016/s0959-8049(99)00210-5. Eur J Cancer. 2000. PMID: 10741290 No abstract available.

10

[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].

du Bois A, Lück HJ, Pfisterer J, Meier W, Bauknecht T. du Bois A, et al. Zentralbl Gynakol. 2000;122(5):255-67. Zentralbl Gynakol. 2000. PMID: 10857212 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page